BioLASCO Taiwan Co., Ltd.
6662.TWO
Price:
$31.75
Market Cap:
$813.18M
BioLASCO Taiwan Co., Ltd. provides bio-materials and surgical services in Taiwan and internationally. It breeds and produces SPF laboratory rats and mice, including outbreed stocks, inbreed strains, and immune deficient models, as well as offers special animal model services. The company also provides endotoxin detection, animal heath diagnostic, and serological kits, as well as biological indicators. In addition, it offers IVC systems and ventilated houses equipment; professional and automated animal watering systems; transponders; chlorine dioxide gas generators; mouse and rat tail cuff blood pressure systems, analgesia equipment, and animal behavioral equipment; metabolism and behavior sy...[Read more]
Industry
Biotechnology
IPO Date
2018-01-04
Stock Exchange
TWO
Ticker
6662.TWO
PE Ratio
[18.14]
ROE
[11.19%]
Current Ratio
[2.48]
Dividend Yield
[4.72%]
Enterprise Value
[811.96M]
Dividend History
The ROE as of December 2025 (TTM) for BioLASCO Taiwan Co., Ltd. (6662.TWO) is 11.19%
According to BioLASCO Taiwan Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 11.19%. This represents a change of 303.75% compared to the average of 2.77% of the last 4 quarters.
BioLASCO Taiwan Co., Ltd. (6662.TWO) Historical ROE (quarterly & annually)
How has 6662.TWO ROE performed in the past?
The mean historical ROE of BioLASCO Taiwan Co., Ltd. over the last ten years is 8.85%. The current 11.19% ROE has changed 26.40% with respect to the historical average. Over the past ten years (40 quarters), 6662.TWO's ROE was at its highest in in the December 2024 quarter at 4.30%. The ROE was at its lowest in in the December 2022 quarter at 0%.
Average
8.85%
Median
9.80%
Minimum
0%
Maximum
13.43%
BioLASCO Taiwan Co., Ltd. (6662.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of BioLASCO Taiwan Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 13.43%
Minimum Annual Increase = -26.94%
Minimum Annual ROE = 0%
| Year | ROE | Change |
|---|---|---|
| 2024 | 9.80% | -9.17% |
| 2023 | 10.79% | 15.90% |
| 2022 | 9.31% | -5.12% |
| 2021 | 9.81% | -26.94% |
| 2020 | 13.43% | Infinity% |
BioLASCO Taiwan Co., Ltd. (6662.TWO) Average ROE
How has 6662.TWO ROE performed in the past?
The current ROE of BioLASCO Taiwan Co., Ltd. (6662.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.96%
5-year avg
10.62%
10-year avg
8.85%
BioLASCO Taiwan Co., Ltd. (6662.TWO) ROE vs. Peers
How is 6662.TWO’s ROE compared to its peers?
BioLASCO Taiwan Co., Ltd.’s ROE is less than Level Biotechnology Inc. (12.44%), less than Concord Medical Co., Ltd. (7.90%), greater than Andros Pharmaceuticals Co.,Ltd (-18.09%), greater than SynCore Biotechnology Co.,Ltd (-18.31%), greater than Eusol Biotech Co.,Ltd. (-10.52%), less than TCI GENE Inc. (3.64%), less than Amed Co., Ltd. (5.43%), greater than TFBS Bioscience Inc. (-4.90%), greater than TaiwanJ Pharmaceuticals Co., Ltd. (-28.55%), greater than NatureWise Biotech & Medicals Corporation (-5.58%),
| Company | ROE | Market cap |
|---|---|---|
| 12.44% | $1.08B | |
| 7.90% | $899.99M | |
| -18.09% | $1.22B | |
| -18.31% | $905.50M | |
| -10.52% | $835.70M | |
| 3.64% | $984.26M | |
| 5.43% | $882.00M | |
| -4.90% | $751.21M | |
| -28.55% | $641.78M | |
| -5.58% | $1.04B |
Build a custom stock screener for BioLASCO Taiwan Co., Ltd. (6662.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioLASCO Taiwan Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BioLASCO Taiwan Co., Ltd. (6662.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BioLASCO Taiwan Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is BioLASCO Taiwan Co., Ltd.'s ROE?
How is the ROE calculated for BioLASCO Taiwan Co., Ltd. (6662.TWO)?
What is the highest ROE for BioLASCO Taiwan Co., Ltd. (6662.TWO)?
What is the 3-year average ROE for BioLASCO Taiwan Co., Ltd. (6662.TWO)?
What is the 5-year average ROE for BioLASCO Taiwan Co., Ltd. (6662.TWO)?
How does the current ROE for BioLASCO Taiwan Co., Ltd. (6662.TWO) compare to its historical average?